Sarah Cannon Blood Cancer Network Leaders to Present 18 Abstracts at the 2018 BMT Tandem Meetings
February 21 2018 - 9:30AM
Business Wire
Today, Sarah Cannon, the Cancer Institute of HCA Healthcare,
announced that 18 abstracts authored by members of the Sarah Cannon
Blood Cancer Network have been selected for presentation at the
2018 BMT Tandem Meetings. Held in Salt Lake City, Utah, from
February 21-25, the BMT Tandem Meetings are hosted by the American
Society for Blood and Marrow Transplantation (ASBMT) and the Center
for International Blood & Marrow Transplant Research (CIBMTR),
and bring together blood cancer experts from around the world to
discuss the latest developments in hematopoietic stem cell
transplantation (HCT).
“We look forward to sharing the advancements made in blood and
marrow transplantation research from across the Sarah Cannon Blood
Cancer Network with our colleagues at the 2018 BMT Tandem
Meetings,” said Fred LeMaistre, MD, Senior Vice President of Market
Operations and Physician-in-Chief of Blood Cancers at Sarah Cannon.
“Together, the experts that form our network are helping redefine
blood cancer care for patients across the U.S. and the UK.”
Noteworthy presentations include:
- A poster presentation by Carlos R.
Bachier, MD, Director of Blood & Marrow Transplant Research at
Sarah Cannon, who will discuss “Open-Label Study to Determine the
Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell
Transplant for Multiple Myeloma” on February 21 in the Salt Palace
Convention Center - Hall E from 6:45-7:45pm.
- A poster presentation by Lisa Cantwell,
Quality Coordinator with Sarah Cannon Center for Blood Cancers at
South Austin Medical Center, who will present “Four Days
Tbo-Filgrastim for Mobilization and Collection Demonstrates
Superior CD34+ Yields, Less Use of Plerixafor, Fewer Collections
and a Decrease in Total Charges” on February 21 in the Salt Palace
Convention Center - Hall E from 6:45-7:45pm.
- A poster presentation by Darby Siler,
Clinical Oncology Pharmacist with Sarah Cannon Center for Blood
Cancer at TriStar Centennial Medical Center, who will discuss
“Reduced-dose Posaconazole as Antifungal Prophylaxis in Allogeneic
Stem Cell Transplant Recipients” on February 24 in the Salt Palace
Convention Center - Hall E from 6:45-7:45pm.
The Sarah Cannon Blood Cancer Network is one of the largest
providers of hematopoietic cell transplantation (HCT). It conducts
more than 1,000 transplants annually through six FACT accredited
transplant centers, and has completed more than 14,000 transplants
since the inception of its first program.
The 18 abstracts and presentations represent studies being
conducted by investigators from Sarah Cannon in affiliation
with Texas Transplant Institute at Methodist Hospital in San
Antonio, Texas, Colorado Blood Cancer Institute at Presbyterian/St.
Luke’s Medical Center in Denver, Colo., Tulane Medical Center in
New Orleans, La., Sarah Cannon Center for Blood Cancers at South
Austin Medical Center in Austin, Texas, Medical City Dallas in
Dallas, Texas, and Sarah Cannon Center for Blood Cancer at TriStar
Centennial Medical Center in Nashville, Tenn.
To learn more about Sarah Cannon’s presence at the BMT Tandem
Meetings, visit www.sarahcannon.com/campaigns/bmttandem2018.
About The Sarah Cannon Blood Cancer Network
Sarah Cannon brings together physician-led blood cancer programs
across the United States and United Kingdom to offer patients
convenient access to care including hematopoietic cell
transplantation (HCT) and clinical trials. The Sarah Cannon Blood
Cancer Network programs include St. David’s South Austin Medical
Center in Austin, Texas, Medical City Dallas in Dallas, Texas,
Colorado Blood Cancer Institute at Presbyterian/St. Luke’s Medical
Center- HealthONE in Denver, Colo., HCA Midwest Health- Research
Medical Center, in Kansas City, Mo., Sarah Cannon Center for Blood
Cancer at TriStar Centennial Medical Center in Nashville, Tenn.,
Tulane Medical Center in New Orleans, La., Texas Transplant
Institute at Methodist Hospital in San Antonio, Texas, Harley
Street at UCH in London and The Christie Clinic in Manchester,
England. For more information about the Network and Sarah Cannon’s
full suite of oncology services, visit sarahcannon.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180221005342/en/
The Sarah Cannon Blood Cancer NetworkSamantha
Maxwellsamantha.maxwell@sarahcannon.com